Circa Group AS

Circa Group AS EBIT/Assets

Delisted

The Operating Income to Assets Ratio (EBIT/Assets) of Circa Group AS (CIRCA.OL) as of Oct 23, 2026 is -16.60 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -13.87 % — a change of 19.72% (lower).

EBIT/Assets

-16.60 %

YoY

19.72%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Circa Group AS is 2023 -16.60 % . Operating Income to Assets Ratio (EBIT/Assets) of Circa Group AS was 2022 -13.87 % . It decreases by 19.72% lower compared to the previous year.

The Circa Group AS EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2020
-24.13 EUR
Jan 1, 2021
-13.81 EUR
Jan 1, 2022
-13.87 EUR
Jan 1, 2023
-16.60 EUR
The Circa Group AS EBIT/Assets history
YEAREBIT/AssetsYoY
-16.60 %+19.72%
-13.87 %+0.42%
-13.81 %-42.77%
-24.13 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Circa Group AS Stock analysis

What does Circa Group AS do? Circa Group AS produces biochemicals through its proprietary Furacell process, converting biomass into advanced bio-based chemicals. The company's product portfolio includes Cyrene, a bio-solvent derived from Levoglucosenone (LGO), which serves as a greener alternative to traditional toxic solvents in paints, coatings, battery, and textile applications. The company develops flavorings, biopolymers, and bio-solvents under development, with Cyrene being a key product for industrial processes requiring safer solvents. Subsidiaries such as Circa Sustainable Chemicals Pty Ltd, Circa Sustainable Chemicals SAS, Circa Sustainable Chemicals BV, and Circa Group Pty. Ltd. support the company's global operations. Circa Group AS sells its biochemical products primarily to industries requiring sustainable chemical solutions, including paint and coating manufacturers, battery producers, and textile companies. The company's focus on eco-friendly solvents like Cyrene targets markets seeking safer alternatives to conventional toxic solvents. By leveraging its Furacell process, Circa Group AS differentiates its offerings as advanced bio-based chemicals with improved environmental and performance profiles. The company's revenue streams are derived from the sale of its biochemical products, particularly Cyrene and other bio-solvents, to industrial clients across multiple sectors. Its subsidiaries facilitate regional market access and operational efficiency, supporting the commercialization of its proprietary technology. As a biotechnology firm, Circa Group AS monetizes its proprietary Furacell process by converting biomass into high-demand sustainable chemicals. Circa Group AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Circa Group AS stock

Operating Income to Assets Ratio (EBIT/Assets) of Circa Group AS is -16.60 % in 2023.

Operating Income to Assets Ratio (EBIT/Assets) of Circa Group AS changed from -13.87 % to -16.60 %, representing a 19.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Circa Group AS since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Circa Group AS with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Circa Group AS

All Key Metrics — Circa Group AS